The Inflammatory Kinase MAP4K4 Promotes Reactivation of Kaposi's Sarcoma Herpesvirus and Enhances the Invasiveness of Infected Endothelial Cells

Kaposi's sarcoma (KS) is a mesenchymal tumour, which is caused by Kaposi's sarcoma herpesvirus (KSHV) and develops under inflammatory conditions. KSHV-infected endothelial spindle cells, the neoplastic cells in KS, show increased invasiveness, attributed to the elevated expression of metalloproteinases (MMPs) and cyclooxygenase-2 (COX-2). The majority of these spindle cells harbour latent KSHV genomes, while a minority undergoes lytic reactivation with subsequent production of new virions and viral or cellular chemo- and cytokines, which may promote tumour invasion and dissemination. In order to better understand KSHV pathogenesis, we investigated cellular mechanisms underlying the lytic reactivation of KSHV. Using a combination of small molecule library screening and siRNA silencing we found a STE20 kinase family member, MAP4K4, to be involved in KSHV reactivation from latency and to contribute to the invasive phenotype of KSHV-infected endothelial cells by regulating COX-2, MMP-7, and MMP-13 expression. This kinase is also highly expressed in KS spindle cells in vivo. These findings suggest that MAP4K4, a known mediator of inflammation, is involved in KS aetiology by regulating KSHV lytic reactivation, expression of MMPs and COX-2, and, thereby modulating invasiveness of KSHV-infected endothelial cells.

• Publication year

  2013

• Venue

  PLoS Pathogens

• Publication date

  2013-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.ppat.1003737PMID 24244164PMCID 3820715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of the B Cell Antigen Receptor Triggers Reactivation of Latent Kaposi's Sarcoma-Associated Herpesvirus in B Cells

  2013cited by this paper
• Tousled-like kinases modulate reactivation of gammaherpesviruses from latency.

  2013cited by this paper
• Effects of enzymatic activation on the distribution of fluorescently tagged MMP-2 cleavable peptides in cancer cells and spheroids.

  2012cited by this paper
• Expression and prognostic significance of MAP4K4 in lung adenocarcinoma.

  2012cited by this paper
• Phosphatase of regenerating liver‐3 promotes migration and invasion by upregulating matrix metalloproteinases‐7 in human colorectal cancer cells

  2012cited by this paper
• Deletion of Kaposi's Sarcoma-Associated Herpesvirus FLICE Inhibitory Protein, vFLIP, from the Viral Genome Compromises the Activation of STAT1-Responsive Cellular Genes and Spindle Cell Formation in Endothelial Cells

  2011influential reference
• Kaposi's sarcoma‐associated herpesviral IL‐6 and human IL‐6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation

  2011cited by this paper
• Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's Sarcoma-associated herpesvirus by herpes simplex virus type 1

  2011cited by this paper
• KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition.

  2011cited by this paper
• Matrix metalloproteinases.

  2010cited by this paper
• Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances.

  2010cited by this paper
• Kaposi's Sarcoma Associated Herpes Virus (KSHV) Induced COX-2: A Key Factor in Latency, Inflammation, Angiogenesis, Cell Survival and Invasion

  2010cited by this paper
• Matrix metalloproteinases 2 and 9, and extracellular matrix in Kaposi's sarcoma

  2010cited by this paper
• ShRNA-Targeted MAP4K4 Inhibits Hepatocellular Carcinoma Growth

  2010cited by this paper
• KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.

  2010cited by this paper
• Lowered HGK expression inhibits cell invasion and adhesion in hepatocellular carcinoma cell line HepG2.

  2010cited by this paper
• Regulation of the immune response by stress‐activated protein kinases

  2009influential reference
• Control of Promatrilysin (MMP7) Activation and Substrate-specific Activity by Sulfated Glycosaminoglycans*

  2009cited by this paper
• The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.

  2009cited by this paper
• Map4k4 Negatively Regulates Peroxisome Proliferator-activated Receptor (PPAR) γ Protein Translation by Suppressing the Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Cultured Adipocytes*

  2009cited by this paper
• Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction.

  2009cited by this paper
• Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation

  2009influential reference
• Toll-like receptor signaling controls reactivation of KSHV from latency

  2009cited by this paper
• Kaposi's Sarcoma-Associated Herpesvirus Upregulates Angiogenin during Infection of Human Dermal Microvascular Endothelial Cells, Which Induces 45S rRNA Synthesis, Antiapoptosis, Cell Proliferation, Migration, and Angiogenesis

  2009cited by this paper
• Synthetic Gene Regulation Circuits for Control of Cell Expansion

  2009cited by this paper
• KSHV Reactivation from Latency Requires Pim-1 and Pim-3 Kinases to Inactivate the Latency-Associated Nuclear Antigen LANA

  2009cited by this paper
• Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression.

  2009cited by this paper
• Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways.

  2008influential reference
• A quantitative analysis of kinase inhibitor selectivity

  2008influential reference
• PAX2 expression by HHV-8-infected endothelial cells induced a proangiogenic and proinvasive phenotype.

  2008cited by this paper
• Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality.

  2008cited by this paper
• Aberrant activation of stress-response pathways leads to TNF-α oversecretion in Fanconi anemia. Commentary

  2008cited by this paper
• Aberrant activation of stress-response pathways leads to TNF-alpha oversecretion in Fanconi anemia.

  2008influential reference
• Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma

  2008cited by this paper
• Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

  2007cited by this paper
• RNAi screens reveal novel metabolic regulators: RIP140, MAP4k4 and the lipid droplet associated fat specific protein (FSP) 27

  2007cited by this paper
• Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer.

  2007cited by this paper
• Kaposi's sarcoma associated herpesvirus G-protein coupled receptor activation of cyclooxygenase-2 in vascular endothelial cells

  2007cited by this paper
• Regulation of matrix metalloproteinase gene expression

  2007cited by this paper
• Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2.

  2007cited by this paper
• Kaposi's Sarcoma-Associated Herpesvirus Infection Promotes Invasion of Primary Human Umbilical Vein Endothelial Cells by Inducing Matrix Metalloproteinases

  2007cited by this paper
• Research article: QSAR Study of Phenoxypyrimidine Derivatives as Potent Inhibitors of p38 Kinase Using different Chemometric Tools

  2007cited by this paper
• Transcription factors control invasion: AP-1 the first among equals

  2007cited by this paper
• MAP4K4 Gene Silencing in Human Skeletal Muscle Prevents Tumor Necrosis Factor-α-induced Insulin Resistance*

  2007cited by this paper
• Tumor Necrosis Factor α (TNFα) Stimulates Map4k4 Expression through TNFα Receptor 1 Signaling to c-Jun and Activating Transcription Factor 2*

  2007cited by this paper
• An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARγ, adipogenesis, and insulin-responsive hexose transport

  2006cited by this paper
• Interleukin-1 alpha alters the expression of matrix metalloproteinases and collagen degradation by pulp fibroblasts.

  2006cited by this paper
• Cyclooxygenase 2 Induced by Kaposi's Sarcoma-Associated Herpesvirus Early during In Vitro Infection of Target Cells Plays a Role in the Maintenance of Latent Viral Gene Expression

  2006cited by this paper
• Inflammation, a Key Event in Cancer Development

  2006cited by this paper
• Modulation of Host Gene Expression by the K15 Protein of Kaposi's Sarcoma-Associated Herpesvirus

  2006cited by this paper
• Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling

  2006cited by this paper
• Raf/MEK/ERK signalling triggers reactivation of Kaposi's sarcoma-associated herpesvirus latency.

  2006cited by this paper
• The Nck-interacting kinase phosphorylates ERM proteins for formation of lamellipodium by growth factors

  2006cited by this paper
• Inhibition of Matrilysin Expression by Antisense or RNA Interference Decreases Lysophosphatidic Acid–Induced Epithelial Ovarian Cancer Invasion

  2006cited by this paper
• Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development

  2006cited by this paper
• Matrix metalloproteinases and tumor metastasis

  2006cited by this paper
• Matrix metalloproteinases in the progression and regression of Kaposi’s sarcoma

  2006cited by this paper
• Modulation of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by MEK/ERK, JNK, and p38 Multiple Mitogen-Activated Protein Kinase Pathways during Primary Infection

  2006cited by this paper
• Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.

  2006cited by this paper
• Cell signaling pathways engaged by KSHV.

  2006cited by this paper
• The pleiotropic effects of Kaposi's sarcoma herpesvirus

  2006cited by this paper
• A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase.

  2006cited by this paper
• KSHV infection and the pathogenesis of Kaposi's sarcoma.

  2006cited by this paper
• CellProfiler: image analysis software for identifying and quantifying cell phenotypes

  2006cited by this paper
• Review: Human Gammaherpesvirus Cytokines and Chemokine Receptors

  2005cited by this paper
• Role of Notch Signal Transduction in Kaposi's Sarcoma-Associated Herpesvirus Gene Expression

  2005cited by this paper
• A Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 ORF50 Deletion Mutant Is Defective for Reactivation of Latent Virus and DNA Replication

  2005cited by this paper
• Kaposi's Sarcoma-Associated Herpesvirus Induction of AP-1 and Interleukin 6 during Primary Infection Mediated by Multiple Mitogen-Activated Protein Kinase Pathways

  2005cited by this paper
• Decreased Growth of Vhl−/− Fibrosarcomas Is Associated with Elevated Levels of Cyclin Kinase Inhibitors p21 and p27

  2005cited by this paper
• A small molecule–kinase interaction map for clinical kinase inhibitors

  2005cited by this paper
• Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition

  2004cited by this paper
• Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.

  2004cited by this paper
• Inflammatory Cytokines Inhibit Kaposi's Sarcoma-Associated Herpesvirus Lytic Gene Transcription in In Vitro-Infected Endothelial Cells

  2004influential reference
• Host Gene Induction and Transcriptional Reprogramming in Kaposi’s Sarcoma-Associated Herpesvirus (KSHV/HHV-8)-Infected Endothelial, Fibroblast, and B Cells

  2004cited by this paper
• Role of protein kinase C delta in reactivation of Kaposi's sarcoma-associated herpesvirus.

  2004cited by this paper
• Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression.

  2004cited by this paper
• Targeting JNK for therapeutic benefit: from junk to gold?

  2003influential reference
• COX-2 Induction during Murine Gammaherpesvirus 68 Infection Leads to Enhancement of Viral Gene Expression

  2003cited by this paper
• Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.

  2003cited by this paper
• Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo.

  2003cited by this paper
• Kaposi's Sarcoma-Associated Herpesvirus Induces the Phosphatidylinositol 3-Kinase-PKC-ζ-MEK-ERK Signaling Pathway in Target Cells Early during Infection: Implications for Infectivity

  2003cited by this paper
• Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-κB and JNK/AP1 pathways

  2003cited by this paper
• Productive Lytic Replication of a Recombinant Kaposi's Sarcoma-Associated Herpesvirus in Efficient Primary Infection of Primary Human Endothelial Cells

  2003cited by this paper
• Chromatin Remodeling of the Kaposi's Sarcoma-Associated Herpesvirus ORF50 Promoter Correlates with Reactivation from Latency

  2003cited by this paper
• Relationship of Kaposi sarcoma (KS)-associated herpesvirus viremia and KS disease in Zimbabwe.

  2003cited by this paper
• MT1-MMP and MMP-7 in invasion and metastasis of human cancers

  2003cited by this paper
• Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes.

  2003cited by this paper
• Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomegalovirus replication in apolipoprotein-E knockout mice.

  2003cited by this paper
• Induction of matrix metalloproteinase-13 gene expression by TNF-α is mediated by MAP kinases, AP-1, and NF-κB transcription factors in articular chondrocytes

  2003cited by this paper
• Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1.

  2002cited by this paper
• Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication

  2002cited by this paper
• Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy.

  2002cited by this paper
• Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma.

  2002cited by this paper
• Kaposi's Sarcoma-Associated Herpesvirus OX2 Glycoprotein Activates Myeloid-Lineage Cells To Induce Inflammatory Cytokine Production

  2002cited by this paper
• Activation of Monocyte Cyclooxygenase-2 Gene Expression by Human Herpesvirus 6

  2002cited by this paper
• Viral IL-6-Induced Cell Proliferation and Immune Evasion of Interferon Activity

  2002cited by this paper
• The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway.

  2002cited by this paper
• Expression of collagenase‐3 (MMP‐13) enhances invasion of human fibrosarcoma HT‐1080 cells

  2002cited by this paper
• IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways.

  2001cited by this paper
• Early- and late-stage Kaposi's sarcoma-derived cells but not activated endothelial cells can invade de-epidermized dermis.

  2001cited by this paper

• Investigating the mechanism of phthalates in breast cancer using molecular docking and network toxicology

  2025cites this paper
• Integration of Machine Learning, Bioinformatics, and Experimental Validation to Identify Novel Diagnostic and Prognostic Biomarkers Associated With Succinylation in Lung Adenocarcinoma

  2025cites this paper
• Cross Talk between MicroRNAs and Dengue Virus.

  2024cites this paper
• Recruitment of phospholipase Cγ1 to the non-structural membrane protein pK15 of Kaposi Sarcoma-associated herpesvirus promotes its Src-dependent phosphorylation

  2021cites this paper
• KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi’s sarcoma

  2020cites this paper
• Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis

  2019cites this paper
• Arachidonic Acid Derived Lipid Mediators Influence Kaposi’s Sarcoma-Associated Herpesvirus Infection and Pathogenesis

  2019cites this paper
• Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use

  2019cites this paper
• MMP14 in Sarcoma: A Regulator of Tumor Microenvironment Communication in Connective Tissues

  2019cites this paper
• Pathogenesis of Human Gammaherpesviruses: Recent Advances

  2019cites this paper
• Identification of lead anti-human cytomegalovirus compounds targeting MAP4K4 via machine learning analysis of kinase inhibitor screening data

  2018cites this paper
• Human herpesvirus 8 infection DNA positivity is associated with low insulin secretion: A case‐control study in a sub‐Saharan African population with diabetes

  2018cites this paper
• Transformation-induced stress at telomeres is counteracted through changes in the telomeric proteome including SAMHD1

  2018cites this paper
• Decreased miR-34 a promotes growth by regulating MAP 4 K 4 in hepatitis B virus related hepatocellular carcinoma

  2017cites this paper
• Hsa-let-7c-5p augments enterovirus 71 replication through viral subversion of cell signaling in rhabdomyosarcoma cells

  2017cites this paper
• Kaposi sarcoma herpesvirus pathogenesis

  2017cites this paper
• Epidemiological aspects and origin of KSHV

  2017cites this paper
• The expression level of gene MAP4K4 and its clinical effect in cancerous tissue of gastric carcinoma

  2017cites this paper
• The Ser/Thr Kinase MAP4K4 Controls Pro-Metastatic Cell Functions

  2017cites this paper
• Synergizing Engineered Immunotherapy with Molecularly Targeted Cancer Treatment

  2016cites this paper
• Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS

  2016cites this paper
• KSHV-Mediated Angiogenesis in Tumor Progression

  2016influential citation
• Fine-Tuning of the Kaposi’s Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway

  2016cites this paper
• KSHV non-structural membrane proteins involved in the activation of intracellular signaling pathways and the pathogenesis of Kaposi's sarcoma.

  2016cites this paper
• Molecular docking performance evaluated on the D3R Grand Challenge 2015 drug-like ligand datasets

  2016cites this paper
• MAP4K4: an emerging therapeutic target in cancer

  2016cites this paper
• Inhibiting the Recruitment of PLCγ1 to Kaposi’s Sarcoma Herpesvirus K15 Protein Reduces the Invasiveness and Angiogenesis of Infected Endothelial Cells

  2015cites this paper
• Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.

  2015cites this paper
• Engineering Therapeutic Alignments Between Immune Response and Molecularly Targeted Cancer Treatment

  2015cites this paper
• Molecular Biology of KSHV Lytic Reactivation

  2015cites this paper
• Role of Rap2 and its Downstream Effectors in Tumorigenesis.

  2015cites this paper
• Cellular MicroRNA Let-7a Suppresses KSHV Replication through Targeting MAP4K4 Signaling Pathways

  2015cites this paper
• ORF57 Overcomes the Detrimental Sequence Bias of Kaposi's Sarcoma-Associated Herpesvirus Lytic Genes

  2015cites this paper
• Untersuchung zur post-transkriptionellen Genregulation und Virus-Wirtsinteraktionen beim Kaposi's Sarkoma Herpesvirus (KSHV

  2015cites this paper
• The role of Kaposi sarcoma‐associated herpesvirus in the pathogenesis of Kaposi sarcoma

  2015influential citation
• Immunotherapy for tuberculous pericarditis.

  2014cites this paper
• Synergizing immunotherapy with molecular-targeted anticancer treatment.

  2014cites this paper
• Immunotherapy for tuberculous pericarditis.

  2014cites this paper
• Immunotherapy for tuberculous pericarditis.

  2014cites this paper
• Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation.

  2014cites this paper
• Immunotherapy for tuberculous pericarditis.

  2014cites this paper